Cavitation-enhanced delivery of a self-amplifying oncolytic adenovirus for tumour-selective cancer therapy.
Unlike conventional gene therapy, oncolytic adenoviruses selectively infect and replicate within cancer cells, potentially enabling systemically administered yet highly targeted self-amplifying cancer therapy. Until recently, therapeutic efficacy was hindered by limited extravasation of the virus to...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Conference item |
| Publicerad: |
2012
|